Insider Shareholders with Indirect Ownership of Cin Cor Pharma, Inc. (CINC)
This section provides a comprehensive overview of the insiders with indirect ownership of Cin Cor Pharma, Inc. (CINC). You can find the latest updates on their holdings.
CinCor Pharma, Inc. Insider List
Insider | Adquired | Disposed | # of Trades |
---|---|---|---|
Catherine Pearce
Chief Operating Officer |
1,500 | 1,500 | 2 |
Mason Freeman
Chief Medical Officer |
100 | 100 | 2 |
James Healy
Director |
6,079,949 | 6,079,949 | 4 |
General Atlantic Llc
> 10% Shareholder |
4,209,470 | 0 | 2 |
General Atlantic Genpar (Bermuda), L.P.
> 10% Shareholder |
4,209,470 | 0 | 2 |
Sofinnova Venture Partners X, L.P.
> 10% Shareholder |
6,073,949 | 0 | 2 |
5 Am Partners Vi, Llc
> 10% Shareholder |
4,937,646 | 4,937,646 | 3 |
Sofinnova Partners Sas
> 10% Shareholder |
4,220,979 | 0 | 2 |
Mary Theresa Coelho
EVP CFO & Chief BD Officer |
100 | 0 | 1 |